The Effect of Statin Medications on Perioperative and Long-Term Outcomes Following Carotid Endarterectomy or Stenting

Seminars in Vascular Surgery

Volumn 20, Issue 4, 2007, Pages 252-258

  Perler, Bruce A ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; MEVINOLIN; PRAVASTATIN; SIMVASTATIN; STATIN;

ANGIOPLASTY; ARTICLE; CARDIOVASCULAR SURGERY; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; DRUG EFFECT; HUMAN; INCIDENCE; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; PLEIOTROPY; PRIORITY JOURNAL; RESTENOSIS; STENT; STROKE; TREATMENT OUTCOME;

ANGIOPLASTY; CAROTID ARTERY DISEASES; DRUG ADMINISTRATION SCHEDULE; ENDARTERECTOMY, CAROTID; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ODDS RATIO; PREOPERATIVE CARE; RISK ASSESSMENT; RISK FACTORS; STENTS; STROKE; TREATMENT OUTCOME;

EID: 37049015155     PISSN: 08957967     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2007.10.008     Document Type: Article

References (43)

1. Stancu C., and Sima A. Statins: mechanism of action and effects. J Cell Mol Med 5 (2001) 378-387
2. Bellosta S., Ferri N., Bernini F., Paoletti R., and Corsini A. Non-lipid-related effects of statins. Ann Med 32 (2000) 164-176
3. Shepherd J., Cobe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333 (1995) 1301-1307
4. Scandinavian Simvastatin Survival Group. Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
5. Heart Protection Study Collaborative Group. The MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomized placebo-controlled trial. Lancet 360 (2002) 7-22
6. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335 (1996) 1001-1009
7. White H.D., Hines R.J., Anderson N.E., et al. Pravastatin therapy and the risk of stroke. N Engl J Med 243 (2000) 317-326
8. Waters D., Schwart G.G., Olsson A.G., et al. Effects of atorvastatin on stroke in patients with unstable angina or non-Q wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy. Circulation 106 (2002) 1690-1695
9. Amarenco P., Labreuche J., Lavallee P., and Touboul P.J. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35 (2004) 2902-2909
10. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 346 (1995) 1647-1653
11. Crouse III J.R., Byington R.P., Bond M.G., et al. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II). Am J Cardiol 75 (1995) 455-459
12. Nissen S.E., Nicholls S.J., Sipahi I.M.D., et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis. JAMA 295 (2006) 1556-1565
13. Consumer Reports: Best buy drugs. The statin drugs. www.crbestbuydrugs.org Accessed April 10, 2006
14. Mangano D.T., Layug E.L., Walace A., Tateo I., and The Multicenter Study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 335 (1996) 1713-1720
15. Dotani M.I., Elnicki D.M., Jain A.C., and Gibson C.M. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol 86 (2000) 1128-1130
16. Pan W., Pintar T., Anton J., Lee V.V., Vaughn W.K., and Collard C.D. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 110 suppl II (2004) II45-II49
17. Chan A.W., Bhatt D.L., Chew D.P., et al. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation 105 (2002) 691-696
18. Kertai M.D., Boersma E., Westerhout C.M., et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 116 (2004) 96-103
19. Poldermans D., Bax J.J., Kertai M.D., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 (2003) 1848-1851
20. Lindenauer P.K., Pekow P., Wang K., Gutierrez B., and Benjamin E. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 291 (2004) 2092-2099
21. O'Neil-Callahan K., Katsimaglis G., Tepper M.R., et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery. The Statins for Risk Reduction in Surgery (StaRRS) Study. J Am Coll Cardiol 45 (2005) 336-342
22. Durazzo A.E., Machado F.S., Ikeoka D.T., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39 (2004) 967-976
23. Schouten O., Kertai M.D., Bax J.J., et al. Safety of perioperative statin use in high-risk patients undergoing major vascular surgery. Am J Cardiol 95 (2005) 658-660
24. Crouse III J.R., Raichlen J.S., Riley J.S., et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis; the METEOR trial. JAMA 297 (2007) 1344-1353
25. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325 (1991) 445-453
26. Matsen S.L., Chang D.C., Perler B.A., Roseborough G.S., and Williams G.M. Trends in the in-hospital stroke rate following carotid endarterectomy in California and Maryland. J Vasc Surg 44 (2006) 488-495
27. McGirt M.J., Perler B.A., Brooke B.S., et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg 42 (2005) 829-836
28. Kennedy J., Quan H., Buchan A.M., Ghali W., and Feasby T.F. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke 36 (2005) 2072-2076
29. Schonbeck U., and Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as anti-inflammatory agents?. Circulation 109 suppl II (2004) II18-II26
30. Vaughn C.J. Prevention of stroke and dementia with statins: effects beyond lipid lowering. Am J Cardiol 91 suppl (2003) 23B-29B
31. Koh K.K. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Cardiovasc Res 47 (2000) 648-657
32. Sironi L., Cimino M., Guerrini U., et al. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscl Thromb Vasc Biol 23 (2003) 322-327
33. Schouten O., Bax J.J., Dunkelgrun M., et al. Statins for the prevention of perioperative cardiovascular complications in vascular surgery. J Vasc Surg 44 (2006) 419-424
34. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 108 (2003) 1664-1672
35. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 108 (2003) 16772-1778
36. Molloy K.J., Thompson M.M., Schwalbe E.C., Bell P.R.F., Naylor R., and Loftus I.M. Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on versus not on statins preoperatively. Am J Cardiol 94 (2004) 144-146
37. Crisby M., Nordin-Fredriksson G., Shah P.K., Yano J., Zhu J., and Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103 (2001) 926-933
38. Golledge J., Greenhalgh R.M., and Davies A.H. The symptomatic carotid plaque. Stroke 31 (2000) 774-781
39. Groschel K., Ernemann U., Schulz J.B., et al. Statin therapy at carotid angioplasty and stent placement: effect on procedure-related stroke, myocardial infarction, and death. Radiology 240 (2006) 145-151
40. Amarenco P., Labreuche J., Lavallee P., et al. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35 (2004) 2902-2909
41. LaMuraglia G.M., Stoner M.C., Brewster D.C., et al. Determinants of carotid endarterectomy anatomic durability: effects of serum lipids and lipid-lowering drugs. J Vasc Surg 41 (2005) 762-768
42. Heeschen C., Hamm C.W., Laufs U., et al. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 105 (2002) 1446-1452
43. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)-summary of recommendations. J Am Coll Cardiol 47 (2006) 1239-1312